tradingkey.logo
搜尋

KORU Medical Systems Inc

KRMD
添加自選
4.110USD
0.0000.00%
收盤 07-31 16:00美東報價延遲15分鐘
188.78M總市值
虧損本益比TTM

關於 KORU Medical Systems Inc 公司

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc簡介

公司代碼KRMD
公司名稱KORU Medical Systems Inc
上市日期Oct 27, 1993
CEOTharby (Linda M)
員工數量80
證券類型Ordinary Share
年結日Oct 27
公司地址100 Corporate Drive
城市MAHWAH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07430
電話18454692042
網址https://www.korumedical.com/
公司代碼KRMD
上市日期Oct 27, 1993
CEOTharby (Linda M)

KORU Medical Systems Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
51.31K
+6.96%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%

常見問題

KORU Medical Systems Inc的前五大股東是誰?

KORU Medical Systems Inc的前五大股東如下:Ms. Linda M. Tharby

有多少機構持有KORU Medical Systems Inc(KRMD)的股份?

截至2026Q1,共有188家機構持有KORU Medical Systems Inc的股份,合計持有的股份價值約為28.85M,占公司總股份的62.71% 。與2025Q4相比,機構持股有所增加,增幅為-129292.00。

哪個業務部門對KORU Medical Systems Inc的收入貢獻最大?

在2026Q1,Domestic Core業務部門對KORU Medical Systems Inc的收入貢獻最大,創收27.99M,占總收入的68.06% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有